Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-04

Clinical Trial Update: Gabapentin for Alcohol Relapse Prevention [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating gabapentin for relapse prevention in alcohol use disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorder, Alcohol Withdrawal | Phase 2 | Status: COMPLETED | Results posted: 2019-11-04